Recommended For You

Current Standard of Care for Patients with Multiple Myeloma Based on Their Eligibility for Autologous Stem-Cell Transplant

Charise Gleason, MSN, NP-BC, AOCNP, Kathryn Maples, PharmD, BCOP, Chelsea Sprouse, RN-BSN, MSN, NP-C

Charise Gleason, MSN, NP-BC, AOCNP, Kathryn Maples, PharmD, BCOP, and Chelsea Sprouse, RN-BSN, MSN, NP-C, discuss the current standard of care for both high- and low-risk patients with newly diagnosed or recurrent/refractory multiple myeloma who are initially not eligible for autologous stem-cell transplant and who subsequently become transplant-eligible.

Jane Zubia, RN, OCN, CN-BN

Lehigh Valley Cancer Institute
Allentown, PA

Last modified: December 19, 2018

Recommended For You

Jane Zubia, RN, OCN, CN-BN

Popular Articles

The Official Journal of

Suggested Topics:

Recommended For You

Jane Zubia, RN, OCN, CN-BN

Popular Articles

The Official Journal of

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

Please enter your mailing address.

Connect with AONN+

Subscribe to the Journal of Oncology Navigation & Survivorship^®